DIAGNOSTIC UTILITY OF AMACR EXPRESSION TO DIFFERENTIATE PROSTATE CARCINOMA FROM BENIGN HYPERPLASIA OF PROSTATE- A HOSPITAL BASED CROSS-SECTIONAL STUDY
Journal Title: Journal of Evolution of Medical and Dental Sciences - Year 2019, Vol 8, Issue 18
Abstract
BACKGROUND Prostatic carcinoma and Nodular Hyperplasia of Prostate (NHP) account for more than 90% of all prostatic diseases. Also, early symptoms of NHP and prostatic cancers are overlapping. However, the final diagnosis is always based on histopathological examination. Currently Trans-rectal ultrasound-guided core biopsy of prostate is the recommended modality of invasive investigation to rule out cancer in suspected cases. However, the lack of a prostate cancer–specific marker, which can be utilized in conjunction with routine histologic examination, remains a limitation. Few literatures have demonstrated the diagnostic usefulness of alpha-methyl-acyl-CoA-racemase (AMACR) in the detection of prostate cancer. We wanted to find out the sensitivity and specificity of this comparatively new marker and its usefulness in differentiating the benign and malignant lesions of prostate. METHODS All the core biopsies sent to the Department of Pathology from July 2016 to August 2018 were utilised in this observational crosssectional study. Only the biopsy reports which could be confirmed by routine H&E stain were included and reports having suspicious or ambiguous diagnosis by routine H&E stain were excluded from the study for further assessment by immunohistochemistry (IHC) marker under evaluation. For IHC, primary antibody was ‘Rabbit Monoclonal Antibody’ to AMACR. The AMACR staining was graded negative, weak or mild (weak non granular cytoplasmic stain), moderate (granular intensity with weak to moderate intensity), and strong (granular staining with strong intensity). RESULTS Out of a total of 106 cases, 68 cases (64.15%) had confirmed diagnosis of prostatic adenocarcinoma and rest 38 cases (35.85%) had confirmed diagnosis of benign hyperplasia of prostate by routine H & E method. Out of the total of 68 cases of prostatic adenocarcinoma, 60 cases (88.23%) show strong or moderate positive expression of AMACR in neoplastic glands while rest 8 cases (11.77%) show weak or negative expression of AMACR. Out of the total of 38 benign cases, only 2 cases (5.26%) show false positive expression of AMACR. Sensitivity and specificity of this IHC marker came out to be 88.24% and 94.74% respectively. CONCLUSIONS The present study proves that AMACR immunostaining has a very high specificity for diagnosis of prostate adenocarcinoma, but its sensitivity is slightly lower. Careful evaluation of morphologic pattern and combination with basal cell marker with AMACR immunostaining might be more useful for exclusion of prostate cancer in needle biopsy specimen.
Authors and Affiliations
Sanat Biswas, Manas Talukdar
CLINICAL PROFILE OF HENOCH-SCHONLEIN PURPURA IN CHILDREN
BACKGROUND Henoch-Schonlein purpura (HSP) is the most common systemic vasculitis in children. It can produce multisystem involvement. The disease is usually self-limited, but can occasionally produce life-threatening gas...
PFNA v/s PFN IN THE MANAGEMENT OF UNSTABLE INTERTROCHANTERIC FRACTURES
Intertrochantric femoral fractures are common among older age group and are associated with substantial morbidity and mortality a wide variety of treatment modalities are available for the management and man...
RETROSPECTIVE ANALYSIS OF LSIS VERSUS PHARMACOLOGICAL MANAGEMENT IN ACUTE ANAL FISSURE- A STUDY IN ZONAL SERVICE HOSPITAL
BACKGROUND Acute anal fissure is a quite common and extremely painful condition of anal canal. The prevalence of anal fissures has changed due to change in food habits in the Indian subcontinent. Medical management is a...
STUDY ON BACTERIOLOGY OF TONSILLITIS IN A HOSPITAL
[b]OBJECTIVES: [/b]Tonsillitis affects all age groups especially children. Our aim is to find out the main causative agents responsible for causing tonsillitis. [b]METHODS: [/b]The study was performed on 152 patients...
OSTEOCHONDROMA TALUS: A CASE REPORT
Osteochondroma is one of the most common benign bone tumors. The bones of the feet are less commonly involved and few case reports of osteochondroma involving the talus have been reported so far. Osteochondrom...